The Latest in Cythemias

Inhibitor shows promise for hematologic disorders

June 24, 2014

Ruxolitinib improves disease control in PV

June 23, 2014

Cythemias

Studies confirm importance of CALR mutation in PMF

June 20, 2014

Cythemias

FDA removes partial clinical hold on imetelstat

June 13, 2014

Cythemias

Mutations implicated in hematologic disorders

April 30, 2014

New insight into TPO and platelet production

April 8, 2014

Cythemias

FDA places imetelstat trials on hold

March 13, 2014

Nanoparticle therapy active in B-cell malignancies

March 6, 2014

Report reveals detailed data of ruxolitinib in MF

March 1, 2012

Cythemias

JAK inhibitor ruxolitinib improves treatment landscape in MF

June 11, 2011

Cythemias